Are you over 18 and want to see adult content?
More Annotations
A complete backup of eatingbirdfood.com
Are you over 18 and want to see adult content?
A complete backup of mjbandofgold.com
Are you over 18 and want to see adult content?
A complete backup of santiagosbodega.com
Are you over 18 and want to see adult content?
A complete backup of merchking.tumblr.com
Are you over 18 and want to see adult content?
A complete backup of yourenneagramcoach.com
Are you over 18 and want to see adult content?
Favourite Annotations
Naked Science — научно-популярное издание
Are you over 18 and want to see adult content?
Rádio Café Música Sertanejo Caipira - Rádio Café Viola Sertanejo Caipira Patos de Minas MG
Are you over 18 and want to see adult content?
Sudoku gratuits en ligne sur CarresMagiques.com
Are you over 18 and want to see adult content?
Genießen Sie das Seebad Travemünde
Are you over 18 and want to see adult content?
Text
COVID-19.
ABOUT US | INNOPLEXUS Holger Hoffmann. CHIEF FINANCIAL OFFICER – INNOPLEXUS INDIA . Holger Hoffmann is the Chief Financial Officer of Innoplexus India. He brings with him over 20 years of broad international experience in Sales, Finance, Controlling, Joint Ventures, M&A, and Operations within management holdings, family-owned companies, and large industrialcorporations.
INNOPLEXUS AND PAREXEL EXPAND CAPABILITIES OF COVID-19 COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19.. ESCHBORN, Germany, Boston, M.A. and Durham, N.C., May 11, 2021 – Innoplexus, a global leader in AI-based drug discovery and development, and Parexel, a leading global clinical research organization, have expanded the features and functionality HOW DOES ARTIFICIAL INTELLIGENCE WORK? How is artificial intelligence applied? Popular misconceptions tend to place AI on an island with robots and self-driving cars. However, this approach fails to recognize artificial intelligence’s major practical application; processing the vast amounts of data generateddaily.
CAREERS | INNOPLEXUS Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join to do their best work. INNOPLEXUS CONSULTING SERVICES IS PROUD TO ANNOUNCE ISO Pune, India, February 13, 2020 – Innoplexus Consulting Services Private Limited, a subsidiary of Innoplexus AG, is delighted to have been awarded ISO/IEC 27001:2013 certification, a global standard for reducing the risk and improving the security of data. Innoplexus has been committed to achieving the BLOCKCHAIN CAN TAKE PHARMA COLLABORATION AND INNOVATION TO Blockchain can offer solution for pharma researchers to share insights and data in real time while protecting intellectual property ownershiprights.
REAL-TIME, REAL-WORLD DATA IN MODERN CLINICAL RESEARCH Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation. WIE DAS „GOOGLE DER PHARMAINDUSTRIE“ DEN KAMPF …TRANSLATE THISPAGE
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf gegen Covid-19 und Krebs helfen kann. Eine Prognose, wann ein wirksames Mittel auf den Markt kommen kann, wagt er USING AI TO STREAMLINE THE WORK OF REGULATORY AFFAIRS Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation. INNOPLEXUS | ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN SOLUTIONSLIFE SCIENCE AIONTOSIGHTTECHNOLOGYABOUT USRESOURCESBOOK A FREE CONSULTATION Innoplexus and Parexel have launched the COVID-19 Clearinghouse which is a comprehensive online resource for patients, researchers, and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials, and current news related toCOVID-19.
ABOUT US | INNOPLEXUS Holger Hoffmann. CHIEF FINANCIAL OFFICER – INNOPLEXUS INDIA . Holger Hoffmann is the Chief Financial Officer of Innoplexus India. He brings with him over 20 years of broad international experience in Sales, Finance, Controlling, Joint Ventures, M&A, and Operations within management holdings, family-owned companies, and large industrialcorporations.
INNOPLEXUS AND PAREXEL EXPAND CAPABILITIES OF COVID-19 COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19.. ESCHBORN, Germany, Boston, M.A. and Durham, N.C., May 11, 2021 – Innoplexus, a global leader in AI-based drug discovery and development, and Parexel, a leading global clinical research organization, have expanded the features and functionality HOW DOES ARTIFICIAL INTELLIGENCE WORK? How is artificial intelligence applied? Popular misconceptions tend to place AI on an island with robots and self-driving cars. However, this approach fails to recognize artificial intelligence’s major practical application; processing the vast amounts of data generateddaily.
CAREERS | INNOPLEXUS Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join to do their best work. INNOPLEXUS CONSULTING SERVICES IS PROUD TO ANNOUNCE ISO Pune, India, February 13, 2020 – Innoplexus Consulting Services Private Limited, a subsidiary of Innoplexus AG, is delighted to have been awarded ISO/IEC 27001:2013 certification, a global standard for reducing the risk and improving the security of data. Innoplexus has been committed to achieving the BLOCKCHAIN CAN TAKE PHARMA COLLABORATION AND INNOVATION TO Blockchain can offer solution for pharma researchers to share insights and data in real time while protecting intellectual property ownershiprights.
REAL-TIME, REAL-WORLD DATA IN MODERN CLINICAL RESEARCH Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation. WIE DAS „GOOGLE DER PHARMAINDUSTRIE“ DEN KAMPF …TRANSLATE THISPAGE
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf gegen Covid-19 und Krebs helfen kann. Eine Prognose, wann ein wirksames Mittel auf den Markt kommen kann, wagt er USING AI TO STREAMLINE THE WORK OF REGULATORY AFFAIRS Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation. CONTACT | INNOPLEXUS Faster, deeper & broader insights in real time with our AI based platforms and solutions. Get in touch and experience the benefits foryour organization.
INNOPLEXUS CONSULTING SERVICES IS PROUD TO ANNOUNCE ISO Pune, India, February 13, 2020 – Innoplexus Consulting Services Private Limited, a subsidiary of Innoplexus AG, is delighted to have been awarded ISO/IEC 27001:2013 certification, a global standard for reducing the risk and improving the security of data. Innoplexus has been committed to achieving the ARTIFICIAL INTELLIGENCE FOR BETTER CLINICAL TRIAL Innoplexus’ Clinical Trial Prediction engine leverages advanced deep learning with 230+ features to provide insights for optimizing studydesigns.
5 DATA SCIENCE SUCCESS STORIES IN HEALTHCARE We have been awarded ISO/IEC 27001:2013 certification . ISO/IEC 27001:2013 is a global standard for reducing the risk and improving the security of data.JOBS | INNOPLEXUS
Join our rapidly growing team at Innoplexus careers by searching and applying for the vacancies that are most relevant to you. REAL-TIME KOL DISCOVERY & MANAGEMENT WITH AI Instant Access to All Life Sciences Key Opinion Leaders . Ontosight ® Influence is an AI-based, one-stop solution for identifying and managing top and emerging key opinion leaders (KOLs) across the entire drug discovery and development value chain, from the preclinical phase to postlaunch support. How do you find the right KOLs online in your therapeutic area of interest. BLOCKCHAIN CAN TAKE PHARMA COLLABORATION AND INNOVATION TO Blockchain can offer solution for pharma researchers to share insights and data in real time while protecting intellectual property ownershiprights.
FDA SUPPORTS AI FOR DRUG DEVELOPMENT Werner Seiz is the Vice President of Translational Science at Innoplexus. He brings more than 30 years of experience in Clinical Pharmacology and transition of cardiovascular, metabolic, respiratory, and immunology projects from pre-clinics into clinical development up to and including PoC. WHAT IS UNSTRUCTURED DATA? Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation. STANDARD OR CUSTOMIZABLE OR CUSTOM-MADE Finding a Software Solution that aligns with your Business . Data is the heart of a business, and software is its mind. Good software cannot only enhance productivity by offering better and simple solutions to complex problems, but it can also cut costs and decreasedelivery time.
INNOPLEXUS | ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN SOLUTIONSLIFE SCIENCE AIONTOSIGHTTECHNOLOGYABOUT USRESOURCESBOOK A FREE CONSULTATION Innoplexus and Parexel have launched the COVID-19 Clearinghouse which is a comprehensive online resource for patients, researchers, and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials, and current news related toCOVID-19.
ABOUT US | INNOPLEXUS Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project. AI & BLOCKCHAIN TECHNOLOGY Our proprietary CAAV TM framework enables the user to generate insights in real time. Innoplexus’s platform architecture utilizes the CAAV framework, which deploys machine learning to crawl, aggregate, analyze, and visualize life sciences big data thereby enriching and expediting decision-making in the pharmaceutical and life sciences industries. HOW DOES ARTIFICIAL INTELLIGENCE WORK? How does Artificial Intelligence work? Artificial Intelligence garners more frontpage headlines every day. Artificial Intelligence, or AI, is the technology enabling machines to learn from experience and perform human-like tasks. Ping-ponging between utopian and dystopian, opinions vary wildly regarding the current and future applications, or CAREERS | INNOPLEXUS Careers | Innoplexus. Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join toJOBS | INNOPLEXUS
Join our rapidly growing team at Innoplexus careers by searching and applying for the vacancies that are most relevant to you. ACCELERATE BIOMARKER DISCOVERY WITH ARTIFICIAL Biomarkers play a key role in drug discovery . Of all drugs approved by the FDA in 2017, 41% were associated with biomarkers, and the biomarker discovery market is 5 DATA SCIENCE SUCCESS STORIES IN HEALTHCARE After-Summit Meetup. Frankfurt Data Science Meetup-Group will have 5 stories shared by top minds at big companies and startups. Stories that show in action keys to success: effective teams, tools, creativity, workflows and strategy. In order to create data products without compromises in data-driven World. The stage will be full ofHeads of
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. HOW TO DEVELOP ETHEREUM CONTRACT USING PYTHON FLASK Storing data in a database is an integral part of any software application.Whoever has the control of that database is a master of that data. Blockchain technology stores data into the block inside blockchain network.So whenever some node syncs to the network they will get the copy of INNOPLEXUS | ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN SOLUTIONSLIFE SCIENCE AIONTOSIGHTTECHNOLOGYABOUT USRESOURCESBOOK A FREE CONSULTATION Innoplexus and Parexel have launched the COVID-19 Clearinghouse which is a comprehensive online resource for patients, researchers, and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials, and current news related toCOVID-19.
ABOUT US | INNOPLEXUS Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project. AI & BLOCKCHAIN TECHNOLOGY Our proprietary CAAV TM framework enables the user to generate insights in real time. Innoplexus’s platform architecture utilizes the CAAV framework, which deploys machine learning to crawl, aggregate, analyze, and visualize life sciences big data thereby enriching and expediting decision-making in the pharmaceutical and life sciences industries. HOW DOES ARTIFICIAL INTELLIGENCE WORK? How does Artificial Intelligence work? Artificial Intelligence garners more frontpage headlines every day. Artificial Intelligence, or AI, is the technology enabling machines to learn from experience and perform human-like tasks. Ping-ponging between utopian and dystopian, opinions vary wildly regarding the current and future applications, or CAREERS | INNOPLEXUS Careers | Innoplexus. Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join toJOBS | INNOPLEXUS
Join our rapidly growing team at Innoplexus careers by searching and applying for the vacancies that are most relevant to you. ACCELERATE BIOMARKER DISCOVERY WITH ARTIFICIAL Biomarkers play a key role in drug discovery . Of all drugs approved by the FDA in 2017, 41% were associated with biomarkers, and the biomarker discovery market is 5 DATA SCIENCE SUCCESS STORIES IN HEALTHCARE After-Summit Meetup. Frankfurt Data Science Meetup-Group will have 5 stories shared by top minds at big companies and startups. Stories that show in action keys to success: effective teams, tools, creativity, workflows and strategy. In order to create data products without compromises in data-driven World. The stage will be full ofHeads of
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. HOW TO DEVELOP ETHEREUM CONTRACT USING PYTHON FLASK Storing data in a database is an integral part of any software application.Whoever has the control of that database is a master of that data. Blockchain technology stores data into the block inside blockchain network.So whenever some node syncs to the network they will get the copy of AI & BLOCKCHAIN TECHNOLOGY Our proprietary CAAV TM framework enables the user to generate insights in real time. Innoplexus’s platform architecture utilizes the CAAV framework, which deploys machine learning to crawl, aggregate, analyze, and visualize life sciences big data thereby enriching and expediting decision-making in the pharmaceutical and life sciences industries. COMMERCIAL | INNOPLEXUS Innoplexus’ AI–powered Solutions. Access untapped KOL networks based on customized metrics such as therapeutic area and disease subtypes, location, publications, and more. Innoplexus categorizes KOLs into 4 distinct categories: Commercial, Clinical, Thought-Leaders, and Public Speaker. Compare share of voice againstcompetitors across
CONTACT | INNOPLEXUS Faster, deeper & broader insights in real time with our AI based platforms and solutions. Get in touch and experience the benefits foryour organization.
MEDIA | INNOPLEXUS
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic. COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and Read More. September 21, 2020 / Media.DRUG DISCOVERY
Leverage Innoplexus’s life sciences data ocean, which covers 95% of the world-wide web, to discover novel therapies by identifying the connections and interactions between closely and distantly related genes, pathways, molecular targets, and drugs. Access untapped KOL networks based on customized metrics such as therapeutic area anddisease
FDA SUPPORTS AI FOR DRUG DEVELOPMENT FDA supports AI for drug development. AI technologies are more widely used in the pharmaceutical industry today to enable for its extensive review of scientific and medical literature. Extensive data obtained through AI can support the discovery of potential biomarkers, accelerate drug development and identify repurposing opportunities. 1The
ARTIFICIAL INTELLIGENCE FOR BETTER CLINICAL TRIAL Of failed trials, 57% show limited efficacy; poor statistical endpoints or underpowered samples. However, clinical trial failures can be modeled by applying Artificial Intelligence techniques on real-world, outside-trial, and biomedical data sets. Innoplexus’ Clinical Trial Prediction engine leverages advanced deep learningtechniques trained
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. STANDARD OR CUSTOMIZABLE OR CUSTOM-MADE A Customizable Software: If specific features can be added to an off the shelf product, it is known as a customizable product. Much standard software comes with options that allow the integration of additional requirements into the base software. However, customization may require expert assistance. A Custom Software: When a companyrequires
WIE DAS „GOOGLE DER PHARMAINDUSTRIE“ DEN KAMPF …TRANSLATE THISPAGE
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf gegen Covid-19 und Krebs helfen kann. Eine Prognose, wann ein wirksames Mittel auf den Markt kommen kann, wagt er INNOPLEXUS | ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN SOLUTIONSLIFE SCIENCE AIONTOSIGHTTECHNOLOGYABOUT USRESOURCESBOOK A FREE CONSULTATION Innoplexus and Parexel have launched the COVID-19 Clearinghouse which is a comprehensive online resource for patients, researchers, and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials, and current news related toCOVID-19.
ABOUT US | INNOPLEXUS Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project. AI & BLOCKCHAIN TECHNOLOGY Our proprietary CAAV TM framework enables the user to generate insights in real time. Innoplexus’s platform architecture utilizes the CAAV framework, which deploys machine learning to crawl, aggregate, analyze, and visualize life sciences big data thereby enriching and expediting decision-making in the pharmaceutical and life sciences industries. HOW DOES ARTIFICIAL INTELLIGENCE WORK? How does Artificial Intelligence work? Artificial Intelligence garners more frontpage headlines every day. Artificial Intelligence, or AI, is the technology enabling machines to learn from experience and perform human-like tasks. Ping-ponging between utopian and dystopian, opinions vary wildly regarding the current and future applications, or CAREERS | INNOPLEXUS Careers | Innoplexus. Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join toJOBS | INNOPLEXUS
Join our rapidly growing team at Innoplexus careers by searching and applying for the vacancies that are most relevant to you. ACCELERATE BIOMARKER DISCOVERY WITH ARTIFICIAL Biomarkers play a key role in drug discovery . Of all drugs approved by the FDA in 2017, 41% were associated with biomarkers, and the biomarker discovery market is 5 DATA SCIENCE SUCCESS STORIES IN HEALTHCARE After-Summit Meetup. Frankfurt Data Science Meetup-Group will have 5 stories shared by top minds at big companies and startups. Stories that show in action keys to success: effective teams, tools, creativity, workflows and strategy. In order to create data products without compromises in data-driven World. The stage will be full ofHeads of
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. HOW TO DEVELOP ETHEREUM CONTRACT USING PYTHON FLASK Storing data in a database is an integral part of any software application.Whoever has the control of that database is a master of that data. Blockchain technology stores data into the block inside blockchain network.So whenever some node syncs to the network they will get the copy of INNOPLEXUS | ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN SOLUTIONSLIFE SCIENCE AIONTOSIGHTTECHNOLOGYABOUT USRESOURCESBOOK A FREE CONSULTATION Innoplexus and Parexel have launched the COVID-19 Clearinghouse which is a comprehensive online resource for patients, researchers, and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials, and current news related toCOVID-19.
ABOUT US | INNOPLEXUS Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project. AI & BLOCKCHAIN TECHNOLOGY Our proprietary CAAV TM framework enables the user to generate insights in real time. Innoplexus’s platform architecture utilizes the CAAV framework, which deploys machine learning to crawl, aggregate, analyze, and visualize life sciences big data thereby enriching and expediting decision-making in the pharmaceutical and life sciences industries. HOW DOES ARTIFICIAL INTELLIGENCE WORK? How does Artificial Intelligence work? Artificial Intelligence garners more frontpage headlines every day. Artificial Intelligence, or AI, is the technology enabling machines to learn from experience and perform human-like tasks. Ping-ponging between utopian and dystopian, opinions vary wildly regarding the current and future applications, or CAREERS | INNOPLEXUS Careers | Innoplexus. Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join toJOBS | INNOPLEXUS
Join our rapidly growing team at Innoplexus careers by searching and applying for the vacancies that are most relevant to you. ACCELERATE BIOMARKER DISCOVERY WITH ARTIFICIAL Biomarkers play a key role in drug discovery . Of all drugs approved by the FDA in 2017, 41% were associated with biomarkers, and the biomarker discovery market is 5 DATA SCIENCE SUCCESS STORIES IN HEALTHCARE After-Summit Meetup. Frankfurt Data Science Meetup-Group will have 5 stories shared by top minds at big companies and startups. Stories that show in action keys to success: effective teams, tools, creativity, workflows and strategy. In order to create data products without compromises in data-driven World. The stage will be full ofHeads of
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. HOW TO DEVELOP ETHEREUM CONTRACT USING PYTHON FLASK Storing data in a database is an integral part of any software application.Whoever has the control of that database is a master of that data. Blockchain technology stores data into the block inside blockchain network.So whenever some node syncs to the network they will get the copy of AI & BLOCKCHAIN TECHNOLOGY Our proprietary CAAV TM framework enables the user to generate insights in real time. Innoplexus’s platform architecture utilizes the CAAV framework, which deploys machine learning to crawl, aggregate, analyze, and visualize life sciences big data thereby enriching and expediting decision-making in the pharmaceutical and life sciences industries. COMMERCIAL | INNOPLEXUS Innoplexus’ AI–powered Solutions. Access untapped KOL networks based on customized metrics such as therapeutic area and disease subtypes, location, publications, and more. Innoplexus categorizes KOLs into 4 distinct categories: Commercial, Clinical, Thought-Leaders, and Public Speaker. Compare share of voice againstcompetitors across
CONTACT | INNOPLEXUS Faster, deeper & broader insights in real time with our AI based platforms and solutions. Get in touch and experience the benefits foryour organization.
MEDIA | INNOPLEXUS
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic. COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and Read More. September 21, 2020 / Media.DRUG DISCOVERY
Leverage Innoplexus’s life sciences data ocean, which covers 95% of the world-wide web, to discover novel therapies by identifying the connections and interactions between closely and distantly related genes, pathways, molecular targets, and drugs. Access untapped KOL networks based on customized metrics such as therapeutic area anddisease
FDA SUPPORTS AI FOR DRUG DEVELOPMENT FDA supports AI for drug development. AI technologies are more widely used in the pharmaceutical industry today to enable for its extensive review of scientific and medical literature. Extensive data obtained through AI can support the discovery of potential biomarkers, accelerate drug development and identify repurposing opportunities. 1The
ARTIFICIAL INTELLIGENCE FOR BETTER CLINICAL TRIAL Of failed trials, 57% show limited efficacy; poor statistical endpoints or underpowered samples. However, clinical trial failures can be modeled by applying Artificial Intelligence techniques on real-world, outside-trial, and biomedical data sets. Innoplexus’ Clinical Trial Prediction engine leverages advanced deep learningtechniques trained
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. STANDARD OR CUSTOMIZABLE OR CUSTOM-MADE A Customizable Software: If specific features can be added to an off the shelf product, it is known as a customizable product. Much standard software comes with options that allow the integration of additional requirements into the base software. However, customization may require expert assistance. A Custom Software: When a companyrequires
WIE DAS „GOOGLE DER PHARMAINDUSTRIE“ DEN KAMPF …TRANSLATE THISPAGE
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf gegen Covid-19 und Krebs helfen kann. Eine Prognose, wann ein wirksames Mittel auf den Markt kommen kann, wagt er INNOPLEXUS | ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN SOLUTIONSLIFE SCIENCE AIONTOSIGHTTECHNOLOGYABOUT USRESOURCESBOOK A FREE CONSULTATION Innoplexus provides advanced artificial intelligence (AI) and blockchain solutions that support all stages of drug development from pipeline to market. Innoplexus identifies and extracts structured and unstructured life science data by scanning up to 95% of the world-wide-web and merges it with enterprise and third-party data inan ongoing
ABOUT US | INNOPLEXUS Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project. HOW DOES ARTIFICIAL INTELLIGENCE WORK? How does Artificial Intelligence work? Artificial Intelligence garners more frontpage headlines every day. Artificial Intelligence, or AI, is the technology enabling machines to learn from experience and perform human-like tasks. Ping-ponging between utopian and dystopian, opinions vary wildly regarding the current and future applications, or CAREERS | INNOPLEXUS Careers | Innoplexus. Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join to ACCELERATE BIOMARKER DISCOVERY WITH ARTIFICIAL It is unacceptably easy to publish “statistically significant” evidence, which makes it hard to identify crucial results in research Life sciences data, coupled with Innoplexus’s AI and data analytics solutions, can help researchers accurately pinpoint novel biomarkers. Our proprietary technology USING AI TO STREAMLINE THE WORK OF REGULATORY AFFAIRS The tool Innoplexus has developed specifically for regulatory affairs is an AI-powered regulatory drug dashboard. Entirely customizable, the dashboard centralizes the information on important updates from regulatory bodies, including FDA, EMA, TGA, Health Canada, Medsafe, CHMP, PRAC, etc. It can deliver alerts regarding the latest global STANDARD OR CUSTOMIZABLE OR CUSTOM-MADE A Customizable Software: If specific features can be added to an off the shelf product, it is known as a customizable product. Much standard software comes with options that allow the integration of additional requirements into the base software. However, customization may require expert assistance. A Custom Software: When a companyrequires
BETTER DRUG COMMERCIALIZATION STRATEGIES POWERED BY AISEE MORE ONINNOPLEXUS.COM
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. PHARMA & HEALTHCARE ANALYTICS IS GOING TO BE THE NEXT BIGSEE MORE ONINNOPLEXUS.COM
INNOPLEXUS | ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN SOLUTIONSLIFE SCIENCE AIONTOSIGHTTECHNOLOGYABOUT USRESOURCESBOOK A FREE CONSULTATION Innoplexus provides advanced artificial intelligence (AI) and blockchain solutions that support all stages of drug development from pipeline to market. Innoplexus identifies and extracts structured and unstructured life science data by scanning up to 95% of the world-wide-web and merges it with enterprise and third-party data inan ongoing
ABOUT US | INNOPLEXUS Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project. HOW DOES ARTIFICIAL INTELLIGENCE WORK? How does Artificial Intelligence work? Artificial Intelligence garners more frontpage headlines every day. Artificial Intelligence, or AI, is the technology enabling machines to learn from experience and perform human-like tasks. Ping-ponging between utopian and dystopian, opinions vary wildly regarding the current and future applications, or CAREERS | INNOPLEXUS Careers | Innoplexus. Germany – India – USA: We are one of the fastest growing organizations in the AI-space. Innoplexus is a place where people with varied industry and functional backgrounds join to ACCELERATE BIOMARKER DISCOVERY WITH ARTIFICIAL It is unacceptably easy to publish “statistically significant” evidence, which makes it hard to identify crucial results in research Life sciences data, coupled with Innoplexus’s AI and data analytics solutions, can help researchers accurately pinpoint novel biomarkers. Our proprietary technology USING AI TO STREAMLINE THE WORK OF REGULATORY AFFAIRS The tool Innoplexus has developed specifically for regulatory affairs is an AI-powered regulatory drug dashboard. Entirely customizable, the dashboard centralizes the information on important updates from regulatory bodies, including FDA, EMA, TGA, Health Canada, Medsafe, CHMP, PRAC, etc. It can deliver alerts regarding the latest global STANDARD OR CUSTOMIZABLE OR CUSTOM-MADE A Customizable Software: If specific features can be added to an off the shelf product, it is known as a customizable product. Much standard software comes with options that allow the integration of additional requirements into the base software. However, customization may require expert assistance. A Custom Software: When a companyrequires
BETTER DRUG COMMERCIALIZATION STRATEGIES POWERED BY AISEE MORE ONINNOPLEXUS.COM
OUR CONSUMER PERCEPTIONS OF PHARMA SURVEY: TOP TEN 2. Negative views of pharmaceutical companies increase with age. 63% of those over 60 have a “very negative” or “negative” view of pharmaceutical companies, compared to just 36% of 30-39 year-olds. Similarly, 60% of those over 60 believe that drug companies charge unreasonably high prices, compared to just 36% of 18-29 year-olds. PHARMA & HEALTHCARE ANALYTICS IS GOING TO BE THE NEXT BIGSEE MORE ONINNOPLEXUS.COM
ABOUT US | INNOPLEXUS Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project. COMMERCIAL | INNOPLEXUS Innoplexus’ AI–powered Solutions. Access untapped KOL networks based on customized metrics such as therapeutic area and disease subtypes, location, publications, and more. Innoplexus categorizes KOLs into 4 distinct categories: Commercial, Clinical, Thought-Leaders, and Public Speaker. Compare share of voice againstcompetitors across
CONTACT | INNOPLEXUS Faster, deeper & broader insights in real time with our AI based platforms and solutions. Get in touch and experience the benefits foryour organization.
ONTOSIGHT® DISCOVER Ontosight ® Discover is an innovative and intuitive semantic discovery platform which understands biomedical concepts and allows you to see relevant results in context across multiple data sources like publications, clinical trials, congresses, theses, patents and much more – all in one place and real time.. With Ontosight ® Discover you generate intelligence and insights acrossEARLY-STAGE BIOTECH
Accelerating early-stage and clinical drug development . Since 2016, the biotechnology industry has faced unprecedented uncertainty in both Europe and the United States with new competition coming from China and tech-giants. in order to stay ahead Biotech companies will need to leverage and incorporate emerging digital technologies into their R&D processes or be replaced by those who do ARTIFICIAL INTELLIGENCE FOR BETTER CLINICAL TRIAL Of failed trials, 57% show limited efficacy; poor statistical endpoints or underpowered samples. However, clinical trial failures can be modeled by applying Artificial Intelligence techniques on real-world, outside-trial, and biomedical data sets. Innoplexus’ Clinical Trial Prediction engine leverages advanced deep learningtechniques trained
PHARMA & HEALTHCARE ANALYTICS IS GOING TO BE THE NEXT BIG The Indian pharmaceutical industry has emerged as a significant contributor to the global pharmaceutical industry. As per the report by the Federation of Indian Chamber of Commerce and Industries (FICCI), “India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies overJOBS | INNOPLEXUS
Join our rapidly growing team at Innoplexus careers by searching and applying for the vacancies that are most relevant to you. WIE DAS „GOOGLE DER PHARMAINDUSTRIE“ DEN KAMPF …TRANSLATE THISPAGE
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf gegen Covid-19 und Krebs helfen kann. Eine Prognose, wann ein wirksames Mittel auf den Markt kommen kann, wagt er BREAKING DOWN DATA SILOS TO REVOLUTIONIZE PHARMACEUTICAL Breaking down data silos to revolutionize Pharmaceutical Industry. Science is, by its nature, a collaborative discipline. Connecting the dots through data exchange and the analysis of large amounts of data, especially in the life science industry, can make a revolutionarydifference in
__
* __Life Science AI__* __Solutions__
* __Your Role
* __Drug Discovery
* __Clinical
* __Commercial
* __Products
* __Strategic Partnership * __Clinical Trial Prediction * __Biomarker Identification* __DaaS
* __Industry__
* __Pharma
* __CROs
* __Biotechnology
* __Academic Institution* __Ontosight®__
* __Ontosight® Discover * __Ontosight® Explore * __Ontosight® Influence * __Ontosight® Integrate* __Technology
* __About us
* __Resources__
* __Media
* __Events
* __Blogs
* __Book a Free Consultation__
__
* __Life Science AI__* __Solutions__
* __Your Role
* __Drug Discovery
* __Clinical
* __Commercial
* __Products
* __Strategic Partnership * __Clinical Trial Prediction * __Biomarker Identification* __DaaS
* __Industry__
* __Pharma
* __CROs
* __Biotechnology
* __Academic Institution* __Ontosight®__
* __Ontosight® Discover * __Ontosight® Explore * __Ontosight® Influence * __Ontosight® Integrate* __Technology
* __About us
* __Resources__
* __Media
* __Events
* __Blogs
* __Book a Free Consultation__
__
* Life Science AI
____
* Solutions____
* Your Role
* Drug Discovery
* Clinical
* Commercial
* Products
* Strategic Partnership * Clinical Trial Prediction * Biomarker Identification* DaaS
* Industry____
* Pharma
* CROs
* Biotechnology
* Academic Institution* Ontosight®
____
* Ontosight® Discover * Ontosight® Explore * Ontosight® Influence * Ontosight® Integrate* Technology
* About us
* Resources ____
* Media
* Events
* Blogs
* Book a Free Consultation__
*
CUTTING-EDGE DATA ANALYTICS FROM PIPELINE TO MARKET FORP
h
a
r
m
a
|
*
CUTTING-EDGE DATA ANALYTICS FROM PIPELINE TO MARKET FORB
i
o
t
e
c
h
|
*
CUTTING-EDGE DATA ANALYTICS FROM PIPELINE TO MARKET FORCROs
|
ONTOSIGHT® DASHBOARD FOR AI-POWERED INSIGHTS ON COVID-19 Innoplexus seeks to contribute to the effective fight against the coronavirus, with its AI-powered dashboard, freely available worldwide to Covid-19 / SARS-Cov-2 researchers, medical institutes, news portals, governments, and the public. The dashboard will provide precise and comprehensive information on recent global developments concerning Covid-19, and will be continuously updated.Learn more
Access Dashboard
COVID-19 INFORMATION FOR RESEARCHERS, SPONSORS AND PATIENTS Innoplexus and Parexel have launched the COVID-19 Clearinghouse which is a comprehensive online resource for patients, researchers, and clinical trial sponsors to directly access publications, datasets, links to active global clinical trials, and current news related toCOVID-19.
Learn more
ACCESS COVID-19 CLEARINGHOUSE REAL-TIME, ACTIONABLE INSIGHTS POWERED BY AI Innoplexus provides advanced artificial intelligence (AI) and blockchain solutions that support all stages of drug development from pipeline to market. Innoplexus identifies and extracts structured and unstructured life science data by scanning up to 95% of the world-wide-web and merges it with enterprise and third-party data in an ongoing, real-time process. This continually updated data repository is the foundation of our custom and off-the-shelf solutions that serve pharmaceutical companies, the biotech industry, and contract research organizations. ONTOSIGHT® – ACCELERATE THE DRUG DEVELOPMENT PROCESS Ontosight® offers the largest searchable library of life sciences information to help companies develop accurate therapies much faster, saving them time and costs. The platform applies proprietary AI technologies along with our life sciences ontology to crawl, aggregate, analyze, and visualize life sciences data from multiple published, unpublished, third-party, and enterprise sources. This one stop solution for life sciences comes with various modules and dashboards to help you optimize work potential with the most relevant knowledge, real-time intelligence, and discovery of new patterns across pre-clinical, clinical, regulatory and commercial phases of drug development.Learn more
ONE PLATFORM FOR ALL DRUG DEVELOPMENT ANSWERS – ONTOSIGHT® ONTOSIGHT® DISCOVER An innovative and intuitive semantic discovery engine that understands biomedical concepts and allows users to see relevant results in context across multiple data sourcesRead More
ONTOSIGHT® EXPLORE
A life sciences–specific search engine that enables exploration, identification, and building of various direct and indirect connections between biological entities such as drugs, targets, pathways, and diseasesRead More
ONTOSIGHT® INFLUENCE Real-time discovery, management, and network analysis of top and emerging key opinion leaders (KOLs) across the entire drug discovery and development value chainRead More
ONTOSIGHT® INTEGRATE A 100% automated, self-service engine that leverages internal and external data for real-time analysis of products/sales performance and status of budget and expensesRead More
OUR STRENGTHS ARE FOCUSED ON FASTER DRUG DISCOVERY PROPRIETARY TECHNOLOGIES Our leading proprietary AI technology for life sciences generates real-time insights and relevant results for better decision-making SELF-LEARNING ONTOLOGY Our self-learning ontology understands the language of life sciences and enables context-based searches across multiple data sources LIFE SCIENCE DATA OCEAN Our technology connects trillions of data points from structured, unstructured, public, third-party, corporate, and unpublished data OUR TECHNOLOGY IS DOMAIN-AGNOSTIC. WE EMPOWER:PHARMA
CROS
BIOTECH
ACADEMIC RESEARCH
PHARMACEUTICAL
INVESTMENT
WHAT OUR CLIENTS SAY "Great technology and data" Having sufficient data and analytical capability is critical to being able to identify potential baseline biomarkers. In working with Innoplexus our expectation was to leverage its technology to pool all of the publicly available patient level data that might help us in delivering on this objective. The Innoplexus team was very fast to develop its strategy to address our request. E. HUGHES, NOVARTIS AG"Real Partnership"
Data analytics is becoming a core competency for Pharma. We do not want to outsource this anymore! I love the fact that you are focused on empowering our analytics teams with your solutions. This is a clear differentiation versus all the competitors. You seem to be working on a true partnership model. C-SUITE, ONE OF THE WORLD'S LARGEST PHARMA COMPANIES ‘’Efficiency and quality’’ Innoplexus using their AI technology delivered what we required on time with great quality. The resilience and expertise made us choose Innoplexus again BUSINESS UNIT HEAD, TOP PHARMA COMPANY"Problem solvers."
“Meet the finish line” effort of Innoplexus helped us make our decision easier for choosing a problem solver. We look forward to working with them more and more. DIRECTOR, STRATEGIC INITIATIVES, TOP PHARMA COMPANY "Cutting edge tech!" Innoplexus has cutting edge technology which could potentially revolutionize Pharmaceutical industry…. I am excited to be working with them. DIRECTOR, MEDICAL AFFAIRS, TOP PHARMA COMPANYFEATURED IN
__
__
LATEST MEDIA & BLOGS May 19, 2021 / Media INNOPLEXUS AND PAREXEL EXPAND CAPABILITIES OF COVID-19 INFORMATIONPLATFORM
COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ... Read More September 24, 2020 / Media PAREXEL AND INNOPLEXUS UNVEIL SINGLE SOURCE OF COVID-19 INFORMATION FOR RESEARCHERS, SPONSORS AND PATIENTS DURING THE PANDEMIC COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and... Read More September 21, 2020 / Media WIE DAS „GOOGLE DER PHARMAINDUSTRIE“ DEN KAMPF GEGEN CORONAGEWINNEN WILL
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz... Read MoreNext »
*
PARTNERING TO MAKE 100,000S COVID-19 PUBLICATIONS SEARCHABLEby Gunjan Bhardwaj
in Artificial Intelligence,
Digitalization
, Drug
Discovery ,
Innovation
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. Gunjan Bhardwaj, CEO Innoplexus d...Read More
*
MACHINE LEARNING AS AN INDISPENSABLE TOOL FOR BIOPHARMAby Stratos Davlos
in Artificial Intelligence,
Pharma
The cost of developing a new drug roughly doubles every nine years (inflation-adjusted) ak...Read More
*
PRECISION MEDICINE AND THE DISCOVERY OF BIOMARKERSby Vatsal Agarwal
in Artificial Intelligence In medicine, a Biomarker is a biological indicator, which can mark a state of a biology an...Read More
FEATURED POSTS
How AI Makes Identifying Biomarkers More Accurate and Efficient Leveraging AI for Drug Discovery in early stage Biotech Companies You Can’t Find the Needle If You Don’t Know It Exists Five Reasons to Embrace Data-Driven Drug Development WANT TO JOIN OUR GREAT TEAM?Careers
CONTACT US
__ __ Customer SupportFOLLOW US
__ __
__
Copyright All Rights Reserved © Innoplexus 2021 | Terms of Service| Privacy Policy
| Impressum
Copyright © 2020 – CuriaTMPRIVACY POLICY
IMPRESSUM
Download Technology Capabilities DOWNLOAD TECHNOLOGY CAPABILITIES How did you hear about us?AdvertisementWord of MouthConferencesSocial MediaNewsSearchOther * Subscribe to our newsletter. Innoplexus needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.
OPTIMIZE YOUR
CLINICAL TRIAL
A clinical trial should test your patients, not your patience. See how Artificial Intelligence can streamline your workflow.Learn more
×
WE HAVE BEEN AWARDED ISO/IEC 27001:2013 CERTIFICATION ISO/IEC 27001:2013 is a global standard for reducing the risk and improving the security of data.×
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0